TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 12359036

Group type: EXPERIMENTAL
Intervention: Contingency management + patch
Number of subjects: 175

Group type: COMPARATOR
Intervention: Relapse prevention + patch
Number of subjects: 175

Group type: COMPARATOR
Intervention: Patch-only
Number of subjects: 175

Group type: COMPARATOR
Intervention: Relapse prevention + contingency management + patch
Number of subjects: 175

Group type: EXPERIMENTAL
Intervention: Weeks when participants met criteria for smoking abstinence
Number of subjects: 175
Study: 10092007

Group type: EXPERIMENTAL
Intervention: Recombinant FMDV Ad5-P1 vaccine
Number of subjects: 3

Group type: COMPARATOR
Intervention: Ad5 wt vaccine
Number of subjects: 3
Study: 7768584

Group type: EXPERIMENTAL
Intervention: Low-salt diet (40 mEq Na+/d)
Number of subjects: 22

Group type: COMPARATOR
Intervention: High-salt diet (200 mEq Na+/d)
Number of subjects: 22
Study: 2107520

Group type: EXPERIMENTAL
Intervention: PRP-D vaccine
Number of subjects: 0

Group type: COMPARATOR
Intervention: PRP vaccine
Number of subjects: 0
Study: 515188

Group type: EXPERIMENTAL
Intervention: Proprioceptive neuromuscular facilitation with maximum resistance
Number of subjects: 50

Group type: COMPARATOR
Intervention: Proprioceptive neuromuscular facilitation patterning without resistance
Number of subjects: 50

Group type: COMPARATOR
Intervention: Weight training
Number of subjects: 50
Study: 6298849

Group type: EXPERIMENTAL
Intervention: Naloxone (10 mg)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13
Study: 30239829

Group type: EXPERIMENTAL
Intervention: efavirenz-based ART
Number of subjects: 150

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 150
Study: 29770623

Group type: EXPERIMENTAL
Intervention: Round loop electrode (LE group)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Punch biopsy forceps (PB group)
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 96
Study: 26915026

Group type: EXPERIMENTAL
Intervention: 8.4% sodium bicarbonate infusion (0.5 mEq/kg/h for the first hour; 0.15 mEq/kg/h until completion of surgery)
Number of subjects: 60

Group type: COMPARATOR
Intervention: 0.9% sodium chloride infusion
Number of subjects: 60
Study: 24953768

Group type: EXPERIMENTAL
Intervention: Tai Chi
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: Tai Chi plus CBI
Number of subjects: 122
Study: 23061240

Group type: EXPERIMENTAL
Intervention: Hydrocodone daily for 30 days (in smokers)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Hydrocodone daily for 30 days (in nonsmokers)
Number of subjects: 0
Study: 20435307

Group type: EXPERIMENTAL
Intervention: Transobturator tapes
Number of subjects: 310
Study: 17275657

Group type: EXPERIMENTAL
Intervention: Intravenous valproate infusion at doses ranging from 7.5 to 41.5 mg/kg and rates of 1.5 to 11 mg/kg per minute
Number of subjects: 18
Study: 16088161

Group type: EXPERIMENTAL
Intervention: Daivobet (calcipotriol/betamethasone dipropionate), 4 weeks followed by calcipotriol, 4 weeks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Tacalcitol, 8 weeks
Number of subjects: 0
Study: 11795622

Group type: EXPERIMENTAL
Intervention: Qigong therapy
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Medication (lofexidine‐HCl)
Number of subjects: 86

Group type: COMPARATOR
Intervention: No-treatment control group
Number of subjects: 86
Study: 10047929

Group type: EXPERIMENTAL
Intervention: L-Dopa (200 mg + 50 mg benserazide, PO)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Triazolam (0.125 mg)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: L-Dopa (600 mg/d for 11 days)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Triazolam (0.125 mg) after chronic treatment
Number of subjects: 22
Study: 7726442

Group type: EXPERIMENTAL
Intervention: Omeprazole 20 mg
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Omeprazole 40 mg
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Ranitidine 25 mg
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Ranitidine 50 mg
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: All treatment groups
Number of subjects: 52
Study: 1688066

Group type: EXPERIMENTAL
Intervention: Epinephrine injection
Number of subjects: 29

Group type: COMPARATOR
Intervention: Terbutaline nebulizer inhalation
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Crossover treatment (both groups)
Number of subjects: 29
Study: 7370603

Group type: EXPERIMENTAL
Intervention: Pasteur antivenom (20-40 ml)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Behringwerke antivenom (60-180 ml)
Number of subjects: 14
Study: 31291417

Group type: EXPERIMENTAL
Intervention: exercise‐citrulline (EC)
Number of subjects: 40

Group type: COMPARATOR
Intervention: control‐placebo
Number of subjects: 40

Group type: COMPARATOR
Intervention: control‐citrulline
Number of subjects: 40

Group type: COMPARATOR
Intervention: exercise‐placebo
Number of subjects: 40
Study: 29898717

Group type: EXPERIMENTAL
Intervention: Capacity building and text messaging intervention
Number of subjects: 354
Study: 27164224

Group type: EXPERIMENTAL
Intervention: Oxytocin
Number of subjects: 63

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 63
Study: 24908656

Group type: EXPERIMENTAL
Intervention: Veliparib 25 mg/m² b.i.d. and TMZ 135 mg/m²/d
Number of subjects: 29
Study: 21926667

Group type: EXPERIMENTAL
Intervention: MEDI-534 (live, attenuated RSV/PIV3 chimeric virus vaccine candidate)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 49
Study: 19453850

Group type: EXPERIMENTAL
Intervention: Putty form demineralized bone matrix (DBM)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Particulate form demineralized bone matrix (DBM)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Open flap debridement (control)
Number of subjects: 25
Study: 17157557

Group type: EXPERIMENTAL
Intervention: Simple oral explanation (SP) + Single home visit (SH)
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: Simple oral explanation (SP) + Repeated home visits (RH)
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: Oral and written explanation (RP) + Single home visit (SH)
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: Oral and written explanation (RP) + Repeated home visits (RH)
Number of subjects: 112
Study: 15901122

Group type: EXPERIMENTAL
Intervention: Protonics system with conventional exercise-based rehabilitation
Number of subjects: 34

Group type: COMPARATOR
Intervention: Conventional exercise-based rehabilitation alone
Number of subjects: 34
Study: 11997821

Group type: EXPERIMENTAL
Intervention: Heparin
Number of subjects: 30

Group type: COMPARATOR
Intervention: Physiological saline solution (PSS)
Number of subjects: 30
Study: 9609266

Group type: EXPERIMENTAL
Intervention: Oral oestriol (3 mg per day)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 72
Study: 8730503

Group type: EXPERIMENTAL
Intervention: alpha 2b‐IFN 3 M.U. thrice a week for six months (Group A)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: alpha 2b‐IFN 3 M.U. thrice a week for 1 year (Group B)
Number of subjects: 36
Study: 2226540

Group type: EXPERIMENTAL
Intervention: Pre-hospital thrombolysis with APSAC
Number of subjects: 0

Group type: COMPARATOR
Intervention: In-hospital thrombolysis
Number of subjects: 0

Group type: COMPARATOR
Intervention: Left ventricular ejection fraction
Number of subjects: 0

Group type: COMPARATOR
Intervention: Total mortality
Number of subjects: 0
Study: 755867

Group type: EXPERIMENTAL
Intervention: Response-specific instructions plus feedback
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Thermal suggestions plus feedback
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Instructions to rest plus feedback
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Response-specific instructions without feedback
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Thermal suggestions without feedback
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Instructions to rest without feedback
Number of subjects: 60
Study: 31162798

Group type: EXPERIMENTAL
Intervention: Oliceridine 0.1 mg
Number of subjects: 401

Group type: EXPERIMENTAL
Intervention: Oliceridine 0.35 mg
Number of subjects: 401

Group type: EXPERIMENTAL
Intervention: Oliceridine 0.5 mg
Number of subjects: 401

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 401

Group type: EXPERIMENTAL
Intervention: Morphine 4 mg
Number of subjects: 401

Group type: EXPERIMENTAL
Intervention: Gastrointestinal adverse events with Oliceridine 0.1 mg
Number of subjects: 401

Group type: EXPERIMENTAL
Intervention: Gastrointestinal adverse events with Oliceridine 0.35 mg
Number of subjects: 401

Group type: EXPERIMENTAL
Intervention: Gastrointestinal adverse events with Oliceridine 0.5 mg
Number of subjects: 401

Group type: EXPERIMENTAL
Intervention: Morphine
Number of subjects: 401

Group type: EXPERIMENTAL
Intervention: Oliceridine 0.35 mg and 0.5 mg
Number of subjects: 401
Study: 27917845

Group type: EXPERIMENTAL
Intervention: Fentanyl and propofol (Group F)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Propofol and suxamethonium (Group S)
Number of subjects: 80
Study: 25499648

Group type: EXPERIMENTAL
Intervention: Kinesio Taping application for 3 days
Number of subjects: 36

Group type: COMPARATOR
Intervention: Inert Kinesio Taping application
Number of subjects: 36
Study: 23271441

Group type: EXPERIMENTAL
Intervention: Live attenuated influenza vaccine (LAIV)
Number of subjects: 9497
Study: 21521389

Group type: EXPERIMENTAL
Intervention: Thalidomide 200 mg daily
Number of subjects: 34

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 34
Study: 18645694

Group type: EXPERIMENTAL
Intervention: Alendronate
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Risedronate
Number of subjects: 84
Study: 16538534

Group type: EXPERIMENTAL
Intervention: Raloxifene (60 or 600 mg daily for 2 weeks)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 37
Study: 14641290

Group type: EXPERIMENTAL
Intervention: Heller's esophagomyotomy (H group)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Heller's esophagomyotomy with 360 degrees floppy Nissen fundoplication (H + N group)
Number of subjects: 20
Study: 10914890

Group type: EXPERIMENTAL
Intervention: Triclosan + pvm/ma + Zn + PPi
Number of subjects: 25

Group type: COMPARATOR
Intervention: Triclosan + pvm/ma
Number of subjects: 25

Group type: COMPARATOR
Intervention: Triclosan + Zn
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study: 8855737

Group type: EXPERIMENTAL
Intervention: Omeprazole 20 mg and clarithromycin 250 mg (OC)
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Omeprazole 20 mg, clarithromycin 250 mg, and metronidazole 500 mg (OCM)
Number of subjects: 65
Study: 1281043

Group type: EXPERIMENTAL
Intervention: Internal radiation therapy by transcatheter hepatic arterial injection of [131I]‐Lp (group A)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Combination therapy of Lp‐TAE (group B)
Number of subjects: 27
Study: 6724847

Group type: EXPERIMENTAL
Intervention: Timolol Maleate (0.5%)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Saline (Control)
Number of subjects: 10
Study: 31193792

Group type: EXPERIMENTAL
Intervention: Online intervention for gambling
Number of subjects: 321

Group type: COMPARATOR
Intervention: No intervention control
Number of subjects: 321
Study: 29100645

Group type: EXPERIMENTAL
Intervention: Subclavian/Axillary access (SCA)
Number of subjects: 202
Study: 26796771

Group type: EXPERIMENTAL
Intervention: Work Productivity and Activity Impairment Questionnaire (WPAI)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Quality and Quantity questionnaire
Number of subjects: 70

Group type: COMPARATOR
Intervention: WHO Health and Work Performance Questionnaire (HPQ)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Work Productivity Scale ‐ Rheumatoid Arthritis
Number of subjects: 70

Group type: COMPARATOR
Intervention: Work Ability Index
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: WPAI
Number of subjects: 70
Study: 25662551

Group type: EXPERIMENTAL
Intervention: Complete suture of the distal incision and relieving incision
Number of subjects: 40

Group type: COMPARATOR
Intervention: Partial suture with only one suture knot for closure of the corner of the flap and closure of the distal incision, without suturing the relieving incision
Number of subjects: 40
Study: 22920718

Group type: EXPERIMENTAL
Intervention: Quetiapine XR 50‐300 mg/day
Number of subjects: 149

Group type: COMPARATOR
Intervention: Divalproex ER 500‐3000 mg/day
Number of subjects: 149

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 149
Study: 21498617

Group type: EXPERIMENTAL
Intervention: latanoprost
Number of subjects: 24

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 24
Study: 18224465

Group type: EXPERIMENTAL
Intervention: Standardized surgical technique for Nissen fundoplication
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standardized surgical technique
Number of subjects: 0
Study: 17135807

Group type: EXPERIMENTAL
Intervention: Clinic-based version of the Four Word Delayed Recall Test
Number of subjects: 644

Group type: EXPERIMENTAL
Intervention: Telephone-based version of the Four Word Delayed Recall Test
Number of subjects: 644

Group type: EXPERIMENTAL
Intervention: Participants in Clinical Dementia Rating stage 0.5
Number of subjects: 644

Group type: EXPERIMENTAL
Intervention: Participants with subjective memory complaints
Number of subjects: 644

Group type: EXPERIMENTAL
Intervention: Participants with low education
Number of subjects: 644

Group type: EXPERIMENTAL
Intervention: Initial testing scores
Number of subjects: 644
Study: 12955018

Group type: EXPERIMENTAL
Intervention: Higher dose of growth hormone (GH) during puberty
Number of subjects: 0

Group type: COMPARATOR
Intervention: Constant rate of growth hormone (GH) during puberty
Number of subjects: 0
Study: 11089383

Group type: EXPERIMENTAL
Intervention: Zoledronic acid
Number of subjects: 0

Group type: COMPARATOR
Intervention: Pamidronate
Number of subjects: 0
Study: 9167371

Group type: EXPERIMENTAL
Intervention: 80 mg of 4% lidocaine spray
Number of subjects: 153

Group type: COMPARATOR
Intervention: Placebo (normal saline) spray
Number of subjects: 153
Study: 8141446

Group type: EXPERIMENTAL
Intervention: Epidural Anesthesia (EA)
Number of subjects: 30

Group type: COMPARATOR
Intervention: General Anesthesia (GA)
Number of subjects: 30
Study: 3277569

Group type: EXPERIMENTAL
Intervention: Terazosin (1, 2, 5, and 10 mg daily) plus atenolol
Number of subjects: 92

Group type: COMPARATOR
Intervention: Placebo plus atenolol
Number of subjects: 92
Study: 31586453

Group type: EXPERIMENTAL
Intervention: Low FODMAP diet
Number of subjects: 52

Group type: COMPARATOR
Intervention: Control diet
Number of subjects: 52
Study: 27992260

Group type: EXPERIMENTAL
Intervention: Unexpected Disturbance Program (UDP)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: UDP
Number of subjects: 21
Study: 28440211

Group type: EXPERIMENTAL
Intervention: Insulin pump therapy
Number of subjects: 317

Group type: COMPARATOR
Intervention: Multiple daily injections (MDI)
Number of subjects: 317
Study: 25511384

Group type: EXPERIMENTAL
Intervention: Ascophyllum nodosum (500 mg dried marine alga powder, ProDen PlaqueOff®)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Negative control tablets
Number of subjects: 61
Study: 24726628

Group type: EXPERIMENTAL
Intervention: Visit-based definition of incident CKD stage 3
Number of subjects: 11560

Group type: EXPERIMENTAL
Intervention: Hospitalization-based definition of incident CKD stage 3
Number of subjects: 11560

Group type: COMPARATOR
Intervention: Hospitalization-based CKD diagnostic code
Number of subjects: 11560
Study: 22623482

Group type: EXPERIMENTAL
Intervention: Anodal tsDCS (2.5 mA, 15 min)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Cathodal tsDCS (2.5 mA, 15 min)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Sham tsDCS (2.5 mA, 15 min)
Number of subjects: 17
Study: 20533573

Group type: EXPERIMENTAL
Intervention: Non-English speakers (Chinese and Spanish)
Number of subjects: 7023

Group type: EXPERIMENTAL
Intervention: Chinese speakers
Number of subjects: 7023

Group type: EXPERIMENTAL
Intervention: Spanish speakers
Number of subjects: 7023

Group type: COMPARATOR
Intervention: English speakers
Number of subjects: 7023
Study: 18411235

Group type: EXPERIMENTAL
Intervention: Nasal continuous positive airway pressure with heliox
Number of subjects: 12

Group type: COMPARATOR
Intervention: Air-oxygen nasal continuous positive airway pressure
Number of subjects: 12
Study: 15754137

Group type: EXPERIMENTAL
Intervention: Deciduous canine dentin
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: MD sectioned deciduous canine dentin
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Cervical area of MD sectioned deciduous canine dentin
Number of subjects: 6

Group type: COMPARATOR
Intervention: Cervical area of BD sectioned premolar dentin
Number of subjects: 6
Study: 12564617

Group type: EXPERIMENTAL
Intervention: Metamax I and II oxygen analysers
Number of subjects: 0

Group type: COMPARATOR
Intervention: Douglas bag technique or Vmax 29 instrument (control methods)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Metamax analysers
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Calculated values from raw data of Metamaxes
Number of subjects: 0
Study: 19667499

Group type: EXPERIMENTAL
Intervention: Venlafaxine XR
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 9368821

Group type: EXPERIMENTAL
Intervention: Very Low Calorie Diet (VLCD) for 12 weeks plus regular dietary and behavioural support over two years
Number of subjects: 113

Group type: COMPARATOR
Intervention: Supportive program only for two years
Number of subjects: 113
Study: 1583392

Group type: EXPERIMENTAL
Intervention: Cholestyramine (6 packets or 24 gm/day)
Number of subjects: 268

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 268
Study: 3709647

Group type: EXPERIMENTAL
Intervention: Cisapride (8 mg)
Number of subjects: 0
Study: 31295003

Group type: EXPERIMENTAL
Intervention: Malignant tumor group
Number of subjects: 246

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 246
Study: 29926300

Group type: EXPERIMENTAL
Intervention: Behavioral PMTCT intervention
Number of subjects: 1398

Group type: COMPARATOR
Intervention: Time-equivalent attention-control condition
Number of subjects: 1398
Study: 26859381

Group type: EXPERIMENTAL
Intervention: Plyometric Training Group (PTG)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control Group (CG)
Number of subjects: 20
Study: 24127266

Group type: EXPERIMENTAL
Intervention: Social media recruitment (n = 138, 51.9%)
Number of subjects: 266

Group type: COMPARATOR
Intervention: Traditional recruitment methods (n = 125, 47.0%)
Number of subjects: 266
Study: 23186026

Group type: EXPERIMENTAL
Intervention: Brief Intervention (BI) - personalized advice added
Number of subjects: 150

Group type: COMPARATOR
Intervention: Minimal Intervention - assessment, feedback, and an informational leaflet
Number of subjects: 150
Study: 20514787

Group type: EXPERIMENTAL
Intervention: Kligman's formula maintenance topical cream program (Group A)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: CO2 fractional resurfacing using high power, fixed pulse width and low frequency (Group B)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Combination of CO2 fractional resurfacing and Kligman's formula maintenance topical cream (Group C)
Number of subjects: 30
Study: 18584251

Group type: EXPERIMENTAL
Intervention: Stool calgranulin B in colorectal cancer patients
Number of subjects: 152

Group type: COMPARATOR
Intervention: Fecal occult blood test
Number of subjects: 152
Study: 15921958

Group type: EXPERIMENTAL
Intervention: Levosimendan
Number of subjects: 29

Group type: COMPARATOR
Intervention: Dobutamine
Number of subjects: 29
Study: 11818756

Group type: EXPERIMENTAL
Intervention: Acute normovolemic hemodilution (ANH)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 80
Study: 10073600

Group type: EXPERIMENTAL
Intervention: CD3-positive T cells
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: CD45RO-positive T cells
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Macrophages
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Fibrin
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Endothelial-associated tissue factor
Number of subjects: 15

Group type: COMPARATOR
Intervention: Control group (thin basement membrane disease)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Control group (humorally mediated glomerulonephritis)
Number of subjects: 15
Study: 7734231

Group type: EXPERIMENTAL
Intervention: Surgical treatment including hip and knee release, aponeurectomy of the iliotibial band, and z-shaped Achilles' tendon lengthening in group I (prophylactic treatment)
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: Surgical treatment including hip and knee release, aponeurectomy of the iliotibial band, and z-shaped Achilles' tendon lengthening in group II (treatment for existing contractures)
Number of subjects: 123

Group type: COMPARATOR
Intervention: Natural history (control group of non-operated DMD patients)
Number of subjects: 123
Study: 8123866

Group type: EXPERIMENTAL
Intervention: Breast cancer cells with high nuclear DNA content (specifically > 5C DNA content)
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: Estrogen receptor (ER) negativity
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: Number of positive lymph nodes
Number of subjects: 93
Study: 4006145

Group type: EXPERIMENTAL
Intervention: Proximal LAD occlusion
Number of subjects: 245

Group type: EXPERIMENTAL
Intervention: RCA occlusion
Number of subjects: 245

Group type: EXPERIMENTAL
Intervention: LAD occlusion
Number of subjects: 245

Group type: EXPERIMENTAL
Intervention: Overall occlusions
Number of subjects: 245

Group type: EXPERIMENTAL
Intervention: Hyperkinesis
Number of subjects: 245
Study: 30977856

Group type: EXPERIMENTAL
Intervention: Mobile telephone use while driving (driving simulator test)
Number of subjects: 182

Group type: EXPERIMENTAL
Intervention: Mobile telephone use while driving (compared to not using a mobile telephone)
Number of subjects: 182
Study: 29733102

Group type: EXPERIMENTAL
Intervention: Proactive telephone support
Number of subjects: 493

Group type: COMPARATOR
Intervention: Reactive support
Number of subjects: 493
Study: 27488888

Group type: EXPERIMENTAL
Intervention: 65% inspiratory resistive breathing tasks (IRBT)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: 2% inspiratory resistive breathing tasks (IRBT)
Number of subjects: 20
Study: 25097285

Group type: EXPERIMENTAL
Intervention: Escitalopram
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Desvenlafaxine
Number of subjects: 0